# AgomAb Therapeutics NV: Form SCHEDULE 13D, filed Feb 17, 2026

- Company: [AgomAb Therapeutics NV](/companies/agmb.md) (CIK 2020932)
- Form: SCHEDULE 13D
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 07:00 ET
- Period: not reported
- Accession: 0001193125-26-052946
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2020932/000119312526052946/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2020932/000119312526052946/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2020932/000119312526052946/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-052946. Last ingested by Listed: Nov 6, 2026, 11:21 ET. No prices; not investment advice.
